ATI-823

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameATI-823
Drug Alias NameAlbrexATI-823
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotransmitter uptake inhibitors
TargetsUpdating
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRti International
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecovery Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsTobacco Use Disorder

Other Information

ATC CodeN/A
Related LinksN/A